Literature DB >> 2005395

Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases.

S Minota1, W N Jarjour, N Suzuki, Y Nojima, R A Roubey, T Mimura, A Yamada, T Hosoya, F Takaku, J B Winfield.   

Abstract

The 110-kDa intracellular phosphoprotein (110K) described previously by this laboratory as a common IgM autoantigen in SLE and certain other systemic autoimmune disorders and viral infections is identified as nucleolin in the present investigation. Using rabbit antiserum to rat nucleolin as a probe, IgM autoantibody-reactive 110K co-migrated with human lymphocyte nucleolin in one- and two-dimensional immunoblots. Rabbit anti-nucleolin also specifically depleted autoreactive 110K from detergent lysates of human cells. Because nucleolin shares amino acid sequence similarity and/or forms dynamic particles with other prominent autoantigens, the present observation raises the possibility that the nucleolin/anti-nucleolin system may be of special significance for the development of humoral autoreactivity to nuclear Ag.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005395

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  B-cell epitopes of scleroderma-specific autoantigens.

Authors:  R Verheijen
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  A Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

3.  Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.

Authors:  Jillian F Wise; Zuzana Berkova; Rohit Mathur; Haifeng Zhu; Frank K Braun; Rong-Hua Tao; Anita L Sabichi; Xue Ao; Hoyoung Maeng; Felipe Samaniego
Journal:  Blood       Date:  2013-04-18       Impact factor: 22.113

4.  Autoantibodies to nucleolin cross-react with histone H1 in systemic lupus erythematosus.

Authors:  W N Jarjour; S Minota; R A Roubey; T Mimura; J B Winfield
Journal:  Mol Biol Rep       Date:  1992-09       Impact factor: 2.316

5.  Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.

Authors:  Jon J Ladd; Timothy Chao; Melissa M Johnson; Ji Qiu; Alice Chin; Rebecca Israel; Sharon J Pitteri; Jianning Mao; Mei Wu; Lynn M Amon; Martin McIntosh; Christopher Li; Ross Prentice; Nora Disis; Samir Hanash
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

Review 6.  Death, autoantigen modifications, and tolerance.

Authors:  P J Utz; T J Gensler; P Anderson
Journal:  Arthritis Res       Date:  2000-02-09

Review 7.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production.

Authors:  Julio E Molineros; Amit K Maiti; Celi Sun; Loren L Looger; Shizhong Han; Xana Kim-Howard; Stuart Glenn; Adam Adler; Jennifer A Kelly; Timothy B Niewold; Gary S Gilkeson; Elizabeth E Brown; Graciela S Alarcón; Jeffrey C Edberg; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Barry I Freedman; Betty P Tsao; Lindsey A Criswell; Chaim O Jacob; Jason H Moore; Timothy J Vyse; Carl L Langefeld; Joel M Guthridge; Patrick M Gaffney; Kathy L Moser; R Hal Scofield; Marta E Alarcón-Riquelme; Scott M Williams; Joan T Merrill; Judith A James; Kenneth M Kaufman; Robert P Kimberly; John B Harley; Swapan K Nath
Journal:  PLoS Genet       Date:  2013-02-18       Impact factor: 5.917

9.  The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.

Authors:  Charalampos Birmpas; Jean Paul Briand; Josẻ Courty; Panagiotis Katsoris
Journal:  Vasc Cell       Date:  2012-12-24

10.  Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus.

Authors:  Wesley H Brooks; Yves Renaudineau
Journal:  Front Genet       Date:  2015-02-16       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.